Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | MET proto-oncogene, receptor tyrosine kinase | Starlite/ChEMBL | References |
Homo sapiens | kinase insert domain receptor | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | TK/KIN16 protein kinase | Get druggable targets OG5_130320 | All targets in OG5_130320 |
Brugia malayi | Immunoglobulin I-set domain containing protein | Get druggable targets OG5_130320 | All targets in OG5_130320 |
Onchocerca volvulus | Tyrosine kinase homolog | Get druggable targets OG5_130320 | All targets in OG5_130320 |
Onchocerca volvulus | Get druggable targets OG5_130320 | All targets in OG5_130320 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | Tyrosine kinase homolog | 0.0172 | 0.1143 | 0.3269 |
Onchocerca volvulus | 0.0482 | 0.3356 | 1 | |
Schistosoma mansoni | plexin | 0.0012 | 0.0006 | 0.0006 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0482 | 0.3356 | 1 |
Brugia malayi | thymidylate synthase | 0.0482 | 0.3356 | 0.3356 |
Schistosoma mansoni | plexin | 0.0021 | 0.0069 | 0.0069 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0184 | 0.1229 | 0.1229 |
Entamoeba histolytica | nicotinate phosphoribosyltransferase, putative | 0.0262 | 0.179 | 0.5 |
Echinococcus multilocularis | nicotinamide phosphoribosyltransferase | 0.1414 | 1 | 1 |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0482 | 0.3356 | 0.3356 |
Brugia malayi | plexin A | 0.0025 | 0.0096 | 0.0096 |
Echinococcus multilocularis | plexin a4 | 0.0025 | 0.0096 | 0.0096 |
Schistosoma mansoni | hypothetical protein | 0.0012 | 0.0006 | 0.0006 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0047 | 0.0047 |
Echinococcus granulosus | thymidylate synthase | 0.0482 | 0.3356 | 0.3356 |
Trypanosoma cruzi | nicotinate phosphoribosyltransferase, putative | 0.0262 | 0.179 | 0.1304 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0482 | 0.3356 | 1 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0184 | 0.1229 | 0.1229 |
Echinococcus multilocularis | roundabout 2 | 0.0018 | 0.0047 | 0.0047 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0026 | 0.0026 |
Echinococcus granulosus | plexin a4 | 0.0025 | 0.0096 | 0.0096 |
Schistosoma mansoni | cell adhesion molecule | 0.0015 | 0.0026 | 0.0026 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0482 | 0.3356 | 0.5 |
Schistosoma mansoni | nephrin | 0.0014 | 0.002 | 0.002 |
Loa Loa (eye worm) | thymidylate synthase | 0.0482 | 0.3356 | 0.3356 |
Echinococcus granulosus | roundabout 2 | 0.0018 | 0.0047 | 0.0047 |
Echinococcus multilocularis | neuroglian | 0.0014 | 0.002 | 0.002 |
Brugia malayi | Plexin repeat family protein | 0.0021 | 0.0069 | 0.0069 |
Echinococcus granulosus | twitchin | 0.0014 | 0.002 | 0.002 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.0482 | 0.3356 | 1 |
Onchocerca volvulus | 0.0167 | 0.1108 | 0.3162 | |
Brugia malayi | hypothetical protein | 0.0229 | 0.1555 | 0.1555 |
Schistosoma mansoni | nicotinate phosphoribosyltransferase related pre-B cell enhancing factor | 0.0262 | 0.179 | 0.179 |
Mycobacterium tuberculosis | Nicotinic acid phosphoribosyltransferase PncB1 | 0.0262 | 0.179 | 0.1304 |
Loa Loa (eye worm) | pre-B cell enhancing factor | 0.1414 | 1 | 1 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0482 | 0.3356 | 0.5 |
Schistosoma mansoni | nicotinate phosphoribosyltransferase related pre-B cell enhancing factor | 0.1414 | 1 | 1 |
Mycobacterium ulcerans | thymidylate synthase | 0.0482 | 0.3356 | 0.5 |
Mycobacterium leprae | PROBABLE THYMIDYLATE SYNTHASE THYA (TS) (TSASE) | 0.0482 | 0.3356 | 0.5 |
Echinococcus granulosus | nicotinamide phosphoribosyltransferase | 0.1414 | 1 | 1 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0482 | 0.3356 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0069 | 0.0069 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0047 | 0.0047 |
Schistosoma mansoni | nicotinate phosphoribosyltransferase | 0.0262 | 0.179 | 0.179 |
Echinococcus multilocularis | thymidylate synthase | 0.0482 | 0.3356 | 0.3356 |
Treponema pallidum | nicotinate phosphoribosyltransferase | 0.0262 | 0.179 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.0006 | 0.0006 |
Echinococcus granulosus | neuroglian | 0.0014 | 0.002 | 0.002 |
Loa Loa (eye worm) | plexin A | 0.0025 | 0.0096 | 0.0096 |
Echinococcus granulosus | neurotracting:lsamp:neurotrimin:obcam | 0.0015 | 0.0026 | 0.0026 |
Leishmania major | dihydrofolate reductase-thymidylate synthase | 0.0482 | 0.3356 | 1 |
Trichomonas vaginalis | nicotinate phosphoribosyltransferase, putative | 0.0262 | 0.179 | 1 |
Mycobacterium tuberculosis | Nicotinic acid phosphoribosyltransferase PncB2 | 0.0262 | 0.179 | 0.1304 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 6.35 uM | Inhibition of human recombinant VEGFR2 pre-incubated for 5 mins before ATP/substrate peptide cocktail addition measured after 30 mins by colorimetric ELISA assay | ChEMBL. | 25082515 |
IC50 (binding) | = 7.48 uM | Inhibition of human recombinant c-Met pre-incubated for 5 mins before ATP/substrate peptide cocktail addition measured after 30 mins by colorimetric ELISA assay | ChEMBL. | 25082515 |
IC50 (functional) | = 64.8 uM | Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay | ChEMBL. | 25082515 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.